Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20448325 | 0.85 | ESR1 (0.35) | — | |
| SCHEMBL10545530 | 0.80 | TAAR1 (0.44) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL28946023 | 0.76 | CHRNA7 (0.42) | LMNAALDH1A1TSHR | |
| SCHEMBL20448331 | 0.74 | DPP4 (0.41) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL465795 | 0.74 | MEN1 (0.40) | KDM4EHIF1AALDH1A1TSHR | |
| SCHEMBL465767 | 0.74 | MAOA (0.40) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL465747 | 0.74 | ESR1 (0.56) | TAAR1KDM4ECYP2D6LMNAHIF1A | |
| SCHEMBL465689 | 0.74 | ADRB2 (0.52) | LMNAHIF1ATSHR | |
| SCHEMBL465711 | 0.72 | TAAR1 (0.43) | TAAR1ADRA2AADRA2CCYP2D6LMNA | |
| SCHEMBL18656958 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119859208-A | Binary free radical polymerization method | 上海交通大学 | 2025-04-22 | — | — | CN | claimed |
| CN-119859208-A | Binary free radical polymerization method | 上海交通大学 | 2025-04-22 | — | — | CN | disclosed |
| WO-2024247968-A1 | DISPERSANT, DISPERSION, INK, INK SET, AND PRINTED MATTER | ａｒｔｉｅｎｃｅ株式会社 | 2024-12-05 | — | — | WO | disclosed |
| WO-2024190876-A1 | DOUBLE-SIDED ADHESIVE TAPE | 積水化学工業株式会社 | 2024-09-19 | — | — | WO | disclosed |
| US-11613662-B2 | Aqueous ink, ink cartridge and ink jet recording method | CANON KABUSHIKI KAISHA (JP) | 2023-03-28 | — | — | US | disclosed |
| CN-111886301-B | White ink, ink set and recording method | 日本化药株式会社 | 2023-01-06 | — | — | CN | disclosed |
| CN-109790423-B | Optical adhesive layer, method for producing optical adhesive layer, optical film with adhesive layer, and image display device | 日东电工株式会社 | 2022-12-06 | — | — | CN | disclosed |
| EP-3865549-B1 | AQUEOUS INK, INK CARTRIDGE AND INK JET RECORDING METHOD | CANON KK (JP) | 2022-11-09 | — | — | EP | disclosed |
| CN-114958090-A | Ink composition and printing method | 日本化药株式会社 | 2022-08-30 | — | — | CN | disclosed |
| US-11401430-B2 | White ink, ink set, and recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2022-08-02 | — | — | US | disclosed |
| US-20070073015-A1 | Polymer, a method for producing the polymer, and a cement admixture using the same | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-03-29 | — | — | US | disclosed |
| EP-1767564-A2 | Polymer, a method for producing the polymer, and a cement admixture using the same | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-03-28 | — | — | EP | disclosed |
| US-20060199927-A1 | Process for production of living-radical polymers and polymers | Outdoor Wireless Networks LLC | 2006-09-07 | — | — | US | disclosed |
| US-20060167199-A1 | Process for produciton of living radical polymers and polymers | OTSUKA CHEMICAL CO., LTD. (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | OTSUKA CHEMICAL CO., LTD. (JP) | 2006-06-22 | — | — | US | disclosed |
| EP-1619211-A1 | PROCESS FOR PRODUCTION OF LIVING-RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2006-01-25 | — | — | EP | disclosed |
| EP-1595894-A1 | PROCESS FOR THE PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-11-16 | — | — | EP | disclosed |
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2005-11-03 | — | — | US | disclosed |
| EP-1541550-A1 | ORGANIC TELLURIUM COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH THE SAME, AND POLYMER | Otsuka Chemical Co., Ltd. (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-1541592-A1 | PROCESS FOR PRODUCTION OF LIVING RADICAL POLYMERS AND POLYMERS | OTSUKA CHEMICAL COMPANY, LIMITED (JP) | 2005-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245714-A1 | Organic tellurium compound, process for producing the same, living radical polymerization initiator, process for producing polymer with the same, and polymer | ODC1, TERB1, TTI1 | TAAR1 219/4885KDM4E 1148/4885ADRA2A 4444/4885 |
| US-20060135711-A1 | Process for the production of living radical polymers and polymers | CBR3, CBR1, CCNT1 | TAAR1 524/4885KDM4E 1142/4885ADRA2A 3690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.